Reumatoloxía

2024

1. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

   Clinical and experimental rheumatology, Vol. 42, Núm. 2, pp. 277-287

2. Anti-Inflammatory Activity of APPA (Apocynin and Paeonol) in Human Articular Chondrocytes

   Pharmaceuticals, Vol. 17, Núm. 1

3. Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis

   RMD Open, Vol. 10, Núm. 3

4. Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease

   Expert Review of Clinical Immunology, Vol. 20, Núm. 9, pp. 1089-1100

5. Can gait patterns be explained by joint structure in people with and without radiographic knee osteoarthritis? Data from the IMI-APPROACH cohort

   Skeletal Radiology

6. Childhood-Onset Non-Infectious Uveitis in the “Biologic Era”. Results From Spanish Multicenter Multidisciplinary Real-World Clinical Settings

   Ocular Immunology and Inflammation

7. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up

   Seminars in Arthritis and Rheumatism, Vol. 66

8. Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials

   Seminars in Arthritis and Rheumatism, Vol. 65

9. Core items to be included in a definition of moderate psoriatic arthritis: literature review and expert opinion

   Rheumatology International

10. Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)

    Rheumatology International

11. Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?

    Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 72-78

12. Early identification of golimumab-treated patients with higher likelihood of long-term retention

    Frontiers in Immunology, Vol. 15

13. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis

    European Journal of Internal Medicine

14. Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting

    Vaccines, Vol. 12, Núm. 6

15. Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature

    Arthritis Research and Therapy, Vol. 26, Núm. 1

16. Exploring candidate biomarkers for rheumatoid arthritis through cardiovascular and cardiometabolic serum proteome profiling

    Frontiers in Immunology, Vol. 15

17. Genetics of vasculitis

    Best Practice and Research: Clinical Rheumatology

18. Higher Synovial Immunohistochemistry Reactivity of IL-17A, Dkk1, and TGF-β1 in Patients with Early Psoriatic Arthritis and Rheumatoid Arthritis Could Predict the Use of Biologics

    Biomedicines, Vol. 12, Núm. 4

19. Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry

    Arthritis Research and Therapy, Vol. 26, Núm. 1

20. Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register

    RMD open, Vol. 10, Núm. 1